Todesco Liliane, Török Michael, Krähenbühl Stephan, Wenk Markus
Department of Internal Medicine, Division of Clinical Pharmacology and Toxicology, University Hospital, 4031 Basel, Switzerland.
Eur J Clin Pharmacol. 2003 Aug;59(4):343-6. doi: 10.1007/s00228-003-0623-1. Epub 2003 Jul 8.
Two mutations in CYP1A2, -164C-->A (allele CYP1A2F) and -3858G-->A (allele CYP1A2C), affecting the inducibility of the enzyme, have been published. The aim of this study was to develop a high throughput allelic discrimination assay for these mutations in both saliva and blood and to determine their frequency in Caucasians.
An allelic discrimination assay, based on the fluorogenic 5'-nuclease activity (TaqMan), was developed for the two mutations. Genomic DNA extracted from 17 saliva and 100 blood samples from Caucasians was analysed.
For the -164C-->A mutation, we found an allelic frequency of 68% in the Caucasian population, comparable with data published for Asians and Caucasians. For the -3858G-->A mutation, the allele frequency was only 2% in Caucasians, a much lower value than the approximately 25% reported in Asians (P<0.001). The presented allelic discrimination allows fast and accurate detection of these two mutations. Genotype calls were 100% identical for DNA from saliva and blood. Saliva is easily accessible and represents an excellent alternative to the traditionally used venous blood for genotyping.
已公布细胞色素P450 1A2(CYP1A2)基因的两种突变,即-164C→A(等位基因CYP1A2F)和-3858G→A(等位基因CYP1A2C),这两种突变影响该酶的诱导性。本研究的目的是开发一种针对唾液和血液中这些突变的高通量等位基因鉴别检测方法,并确定其在高加索人群中的频率。
针对这两种突变开发了一种基于荧光5'-核酸酶活性(TaqMan)的等位基因鉴别检测方法。对从17例高加索人的唾液和100例高加索人的血液样本中提取的基因组DNA进行了分析。
对于-164C→A突变,我们在高加索人群中发现其等位基因频率为68%,与针对亚洲人和高加索人公布的数据相当。对于-3858G→A突变,在高加索人中该等位基因频率仅为2%,远低于亚洲人报道的约25%(P<0.001)。所提出的等位基因鉴别方法能够快速、准确地检测这两种突变。唾液和血液DNA的基因型判定结果100%一致。唾液易于获取,是传统使用的静脉血进行基因分型的极佳替代样本。